[
  {
    "ts": null,
    "headline": "How The Corteva (CTVA) Investment Story Is Shifting As Analysts Rework Targets",
    "summary": "Corteva’s latest fair value estimate has nudged higher, moving from US$82.05 to US$82.76 per share, putting the modeled target firmly in the low US$80s. That shift comes as Street research stays divided, with some firms lifting targets into a similar range while others issue downgrades and question the current risk reward. Read on to see how you can track these changing targets and make sense of the evolving Corteva story for yourself. Analyst Price Targets don't always capture the full...",
    "url": "https://finnhub.io/api/news?id=aa07524372283171da66604d8b6bac3030fa074519be6ca1580b98965d0a3836",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772104312,
      "headline": "How The Corteva (CTVA) Investment Story Is Shifting As Analysts Rework Targets",
      "id": 139230944,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CTVA",
      "source": "Yahoo",
      "summary": "Corteva’s latest fair value estimate has nudged higher, moving from US$82.05 to US$82.76 per share, putting the modeled target firmly in the low US$80s. That shift comes as Street research stays divided, with some firms lifting targets into a similar range while others issue downgrades and question the current risk reward. Read on to see how you can track these changing targets and make sense of the evolving Corteva story for yourself. Analyst Price Targets don't always capture the full...",
      "url": "https://finnhub.io/api/news?id=aa07524372283171da66604d8b6bac3030fa074519be6ca1580b98965d0a3836"
    }
  },
  {
    "ts": null,
    "headline": "A Look At Corteva (CTVA) Valuation After Earnings Miss And Planned Business Separation",
    "summary": "Why Corteva’s restructuring plans are in focus Corteva (CTVA) is back on investors’ radar after its recent earnings report, where revenue came in below expectations and management outlined plans to separate the Seed and Crop Chemicals businesses. At the same time, UBS and JPMorgan downgraded the stock, pointing to execution risks around the breakup and a more cautious outlook. This is helping shape how the market is reassessing Corteva’s story right now. See our latest analysis for...",
    "url": "https://finnhub.io/api/news?id=ddb60c056cd767812ba1b2387f753932727659b1255e761eccda7b30a4ec5307",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772089908,
      "headline": "A Look At Corteva (CTVA) Valuation After Earnings Miss And Planned Business Separation",
      "id": 139229573,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CTVA",
      "source": "Yahoo",
      "summary": "Why Corteva’s restructuring plans are in focus Corteva (CTVA) is back on investors’ radar after its recent earnings report, where revenue came in below expectations and management outlined plans to separate the Seed and Crop Chemicals businesses. At the same time, UBS and JPMorgan downgraded the stock, pointing to execution risks around the breakup and a more cautious outlook. This is helping shape how the market is reassessing Corteva’s story right now. See our latest analysis for...",
      "url": "https://finnhub.io/api/news?id=ddb60c056cd767812ba1b2387f753932727659b1255e761eccda7b30a4ec5307"
    }
  }
]